Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
Use this LCTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LCTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LCTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Lineage Cell Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full LCTX income, balance, and cash tables.